cerrar
Tagged with Canada

NEW Update to Health Canada’s Policy: The Distinction Between…
It is not a secret anymore, many in the industry now know that Health Canada is working on a new version of the policy entitled: The Distinction…

Comprehensive Access to Medicines should be the Priority for…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of prescription drugs. With a new…

The Future of Cannabis and Cosmetics in Canada
In the light of several recent regulatory updates to Canada’s cannabis laws, lawyer Jean-Raphaël Champagne examines the potential for cannabis to…

“To Beat Diabetes, Governments Must Prioritise Patient…
Jan Hux, the president and CEO of Diabetes Canada calls for governments to place greater importance on partnerships with patient groups for the making…

A New Era in Access to Rare Disease Drugs in Canada
Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first article for PharmaBoardroom,…

“Watch Out! Unsophisticated AI in Healthcare Can Perpetuate…
As the healthcare industry continues to hype about AI's potential to be transformative, it is important to remember that even software can harbour a…

Investing in Canadian Health: We Know the Cost, but Can We Talk…
As the President of Innovative Medicines Canada, Pamela Fralick leads the industry association for Canada’s innovative pharmaceutical companies,…

Canada: Targeting Rare Diseases
The research areas in which Canada has the potential to excel are numerous, one being the world of genomics. The stem cell itself having been…

People You Should Know in Canadian Pharma
PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in Canadian pharma’s industry, regulatory affairs,…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Canada
The legal framework for cannabinoid drugs, medical cannabis and opioids in Canada. Prepared in association with Fasken, a leading global law firm,…

Regulatory Reform: Canada
An insight into upcoming regulatory reforms affecting Canadian pharma. Prepared in association with Fasken, a leading global law firm, this is an…

Patents & Trademarks: Canada
The low-down on the situation regarding patents and trademarks in Canadian pharma. Prepared in association with Fasken, a leading global law firm,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here